Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin

Virology

Volumn 255, Issue 1, 1999, Pages 20-25

  Perrin Tricaud, Claire ^a   Davoust, Jean ^b   Jones, Ian M ^a  

^a NATURAL ENVIRONMENT RESEARCH COUNCIL   (United Kingdom)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN PRECURSOR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

EID: 0033102128     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9573     Document Type: Article

References (25)

1. Arthur L. O., Bess J. W., Sowder R. C., Benveniste R. E., Mann D. L., Chermann J.-C., Henderson L. E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
2. Crameri A., Whitehorn E. A., Tate E., Stemmer W. P. C. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nature Bio/Technology. 14:1996;315-319.
3. Dutartre H., Davoust J., Gorvel J. P., Chavrier P. Cytokinesis arrest and redistribution of actin-cytoskeleton regulatory components in cells expressing the Rho GTPase CDC42Hs. J. Cell Sci. 109:1996;367-377.
4. Freed E. O., Orenstein J. M., Buckler-White A. J., Martin M. A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:1994;5311-5320.
5. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
6. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:1989;103-112.
7. Gross I., Hohenberg H., Krausslich H. G. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249:1997;592-600.
8. Holmes H. C. AIDS Reagent Project: Catalogue of Reagents. 1991;National Institute for Biological Standards and Control, Potters Bar.
9. Jones I. M., Morikawa Y. The molecular basis of HIV capsid assembly. Rev. Med. Virol. 8:1998;87-95.
10. Jowett J. B., Hockley D. J., Nermut M. V., Jones I. M. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle. J. Gen. Virol. 73:1992;3079-3086.
11. Krausslich H. G., Welker R. Intracellular transport of retroviral capsid components. Curr. Top. Microbiol. Immunol. 214:1996;25-63.
12. Lee P. P., Linial M. L. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 gag is substituted by a myristyolation signal. J. Virol. 68:1994;6644-6654.
13. Luo L., Li Y., Cannon P. M., Kim S., Kang C. Y. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc. Natl. Acad. Sci. USA. 89:1992;10527-10531.
14. Morikawa Y., Hinata S., Tomoda H., Goto T., Nakai M., Aizawa C., Tanaka H., Omura S. Complete inhibition of human immunodeficiency virus gag myristoylation is necessary for inhibition of particle budding. J. Biol. Chem. 271:1996;2868-2873.
15. Morikawa Y., Zhang W.-H., Hockley D. J., Nermut M. V., Jones I. M. Detection of a trimeric HIV-1 Gag intermediate is dependent on sequences in the matrix protein p17. J. Virol. 72:1998;7659-7663.
16. Nermut M. V., Hockley D. J. Comparative morphology and structural classification of retroviruses. Curr. Top. Microbiol. Immunol. 214:1996;1-24.
17. Ogawa H., Inouye S., Tsuji F. I., Yasuda K., Umesono K. Localization, trafficking, and temperature-dependence of the Aequorea® green fluorescent protein in cultured vertebrate cells. Proc. Natl. Acad. Sci. USA. 2:1995;11899-11903.
18. Perrin C., Fenouillet E., Jones I. Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein. Virology. 242:1998;338-345.
19. Rey O., Canon J., Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology. 220:1996;530-534.
20. Rhee S. S., Hunter E. Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EMBO J. 10:1991;535-546.
21. Sasaki H., Nakamura M., Ohno T., Matsuda Y., Yuda Y., Nonomura Y. Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc. Natl. Acad. Sci. USA. 92:1995;2026-2030.
22. Smith A. J., Srinivasakumar N., Hammmarskjold M.-L., Rekosh D. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67:1993;2266-2275.
23. Vos J. C., Stunnenberg H. G. Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J. 7:1988;3487-3492.
24. Wang C. T., Stegeman Olsen J., Zhang Y., Barklis E. Assembly of HIV Gag-β-galactosidase fusion proteins into virus particles. Virology. 200:1994;524-534.
25. Zhang W. H., Hockley D. J., Nermut M. V., Morikawa Y., Jones I. M. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly. J. Gen. Virol. 77:1996;743-751.